Fatal VAP-related pulmonary aspergillosis by Aspergillus niger in a positive COVID-19 patient

Invasive pulmonary aspergillosis, known as a complication in patients with severe respiratory syndromes, recently showed a correlation with COVID-19 pneumonia, and the clinical characteristics of COVID-19 associated pulmonary aspergillosis (CAPA) have been described. Unfortunately, infections by the...

Full description

Saved in:
Bibliographic Details
Published in:Respiratory medicine case reports 2021-01, Vol.32, p.101367, Article 101367
Main Authors: Trovato, Laura, Calvo, Maddalena, Migliorisi, Giuseppe, Astuto, Marinella, Oliveri, Francesco, Oliveri, Salvatore
Format: Article
Language:English
Subjects:
Aspergillus niger
Case Report
Coinfection
Pulmonary aspergillosis
SARS-CoV-2
Ventilator-associated pneumonia
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c488t-f6f10e5b3806271d255e6c149dd9f4826c4581f8565831a19a36a2765cd308783
cites cdi_FETCH-LOGICAL-c488t-f6f10e5b3806271d255e6c149dd9f4826c4581f8565831a19a36a2765cd308783
container_end_page
container_issue
container_start_page 101367
container_title Respiratory medicine case reports
container_volume 32
creator Trovato, Laura
Calvo, Maddalena
Migliorisi, Giuseppe
Astuto, Marinella
Oliveri, Francesco
Oliveri, Salvatore
description Invasive pulmonary aspergillosis, known as a complication in patients with severe respiratory syndromes, recently showed a correlation with COVID-19 pneumonia, and the clinical characteristics of COVID-19 associated pulmonary aspergillosis (CAPA) have been described. Unfortunately, infections by the Aspergillus genus are often diagnosed in post-mortem time, because of diagnostic delays and a rapid worsening of respiratory conditions. Literature data document, in fact, only few cases of COVID-19 Aspergillus niger coinfection. The aim of this study was to describe a case of a VAP-related probable pulmonary aspergillosis by Aspergillus niger in a COVID-19 patient. Despite the definition of fungal etiology and the rapid administration of antifungal therapy, the patient died while on ventilator support because of severe respiratory impairment.
doi_str_mv 10.1016/j.rmcr.2021.101367
format article
fullrecord <record><control><sourceid>elsevier_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_99045e51ab2e4813a24a43fd55a1f0a0</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2213007121000290</els_id><doaj_id>oai_doaj_org_article_99045e51ab2e4813a24a43fd55a1f0a0</doaj_id><sourcerecordid>S2213007121000290</sourcerecordid><originalsourceid>FETCH-LOGICAL-c488t-f6f10e5b3806271d255e6c149dd9f4826c4581f8565831a19a36a2765cd308783</originalsourceid><addsrcrecordid>eNp9kcFq3DAQhkVoSEKSF-ih6AW81UiWLEMpLNukXQikhyS3ImYleavFaxvJu5C3r1w3IblUF4l_Zr7RzE_IR2ALYKA-7xZxb-OCMw6TIFR1Qi44B1EwVsGHN-9zcp3SjuVT6ZpJfkbOhVBQlxIuyK9bHLGlT8ufRfQtjt7R4dDu-w7jM8U0-LgNbdunkOjmmS5fhEOiXdj6SENHkQ45Poajp6v7p_W3Amo64Bh8N16R0wbb5K__3Zfk8fbmYfWjuLv_vl4t7wpbaj0WjWqAebkRmilegeNSemWhrJ2rm1JzZUupodFSSS0AoUahkFdKWieYrrS4JOuZ63rcmSGGff6-6TGYv0IftwbjGGzrTV2zUnoJuOG-1CCQl1iKxkmJ0DBkmfV1Zg2Hzd47m8eI2L6Dvo904bfZ9kczbVdIkQF8BtjYpxR981oLzEzemZ2ZvDOTd2b2Lhd9etv1teTFqZzwZU7weY_H4KNJNq_Yeheit2MeNPyP_wfp2qm0</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Fatal VAP-related pulmonary aspergillosis by Aspergillus niger in a positive COVID-19 patient</title><source>ScienceDirect</source><source>PubMed Central</source><creator>Trovato, Laura ; Calvo, Maddalena ; Migliorisi, Giuseppe ; Astuto, Marinella ; Oliveri, Francesco ; Oliveri, Salvatore</creator><creatorcontrib>Trovato, Laura ; Calvo, Maddalena ; Migliorisi, Giuseppe ; Astuto, Marinella ; Oliveri, Francesco ; Oliveri, Salvatore</creatorcontrib><description>Invasive pulmonary aspergillosis, known as a complication in patients with severe respiratory syndromes, recently showed a correlation with COVID-19 pneumonia, and the clinical characteristics of COVID-19 associated pulmonary aspergillosis (CAPA) have been described. Unfortunately, infections by the Aspergillus genus are often diagnosed in post-mortem time, because of diagnostic delays and a rapid worsening of respiratory conditions. Literature data document, in fact, only few cases of COVID-19 Aspergillus niger coinfection. The aim of this study was to describe a case of a VAP-related probable pulmonary aspergillosis by Aspergillus niger in a COVID-19 patient. Despite the definition of fungal etiology and the rapid administration of antifungal therapy, the patient died while on ventilator support because of severe respiratory impairment.</description><identifier>ISSN: 2213-0071</identifier><identifier>EISSN: 2213-0071</identifier><identifier>DOI: 10.1016/j.rmcr.2021.101367</identifier><identifier>PMID: 33619451</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Aspergillus niger ; Case Report ; Coinfection ; Pulmonary aspergillosis ; SARS-CoV-2 ; Ventilator-associated pneumonia</subject><ispartof>Respiratory medicine case reports, 2021-01, Vol.32, p.101367, Article 101367</ispartof><rights>2021 The Author(s)</rights><rights>2021 The Author(s).</rights><rights>2021 The Author(s) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c488t-f6f10e5b3806271d255e6c149dd9f4826c4581f8565831a19a36a2765cd308783</citedby><cites>FETCH-LOGICAL-c488t-f6f10e5b3806271d255e6c149dd9f4826c4581f8565831a19a36a2765cd308783</cites><orcidid>0000-0002-0372-8545</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890353/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2213007121000290$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,3536,27901,27902,45756,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33619451$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Trovato, Laura</creatorcontrib><creatorcontrib>Calvo, Maddalena</creatorcontrib><creatorcontrib>Migliorisi, Giuseppe</creatorcontrib><creatorcontrib>Astuto, Marinella</creatorcontrib><creatorcontrib>Oliveri, Francesco</creatorcontrib><creatorcontrib>Oliveri, Salvatore</creatorcontrib><title>Fatal VAP-related pulmonary aspergillosis by Aspergillus niger in a positive COVID-19 patient</title><title>Respiratory medicine case reports</title><addtitle>Respir Med Case Rep</addtitle><description>Invasive pulmonary aspergillosis, known as a complication in patients with severe respiratory syndromes, recently showed a correlation with COVID-19 pneumonia, and the clinical characteristics of COVID-19 associated pulmonary aspergillosis (CAPA) have been described. Unfortunately, infections by the Aspergillus genus are often diagnosed in post-mortem time, because of diagnostic delays and a rapid worsening of respiratory conditions. Literature data document, in fact, only few cases of COVID-19 Aspergillus niger coinfection. The aim of this study was to describe a case of a VAP-related probable pulmonary aspergillosis by Aspergillus niger in a COVID-19 patient. Despite the definition of fungal etiology and the rapid administration of antifungal therapy, the patient died while on ventilator support because of severe respiratory impairment.</description><subject>Aspergillus niger</subject><subject>Case Report</subject><subject>Coinfection</subject><subject>Pulmonary aspergillosis</subject><subject>SARS-CoV-2</subject><subject>Ventilator-associated pneumonia</subject><issn>2213-0071</issn><issn>2213-0071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kcFq3DAQhkVoSEKSF-ih6AW81UiWLEMpLNukXQikhyS3ImYleavFaxvJu5C3r1w3IblUF4l_Zr7RzE_IR2ALYKA-7xZxb-OCMw6TIFR1Qi44B1EwVsGHN-9zcp3SjuVT6ZpJfkbOhVBQlxIuyK9bHLGlT8ufRfQtjt7R4dDu-w7jM8U0-LgNbdunkOjmmS5fhEOiXdj6SENHkQ45Poajp6v7p_W3Amo64Bh8N16R0wbb5K__3Zfk8fbmYfWjuLv_vl4t7wpbaj0WjWqAebkRmilegeNSemWhrJ2rm1JzZUupodFSSS0AoUahkFdKWieYrrS4JOuZ63rcmSGGff6-6TGYv0IftwbjGGzrTV2zUnoJuOG-1CCQl1iKxkmJ0DBkmfV1Zg2Hzd47m8eI2L6Dvo904bfZ9kczbVdIkQF8BtjYpxR981oLzEzemZ2ZvDOTd2b2Lhd9etv1teTFqZzwZU7weY_H4KNJNq_Yeheit2MeNPyP_wfp2qm0</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Trovato, Laura</creator><creator>Calvo, Maddalena</creator><creator>Migliorisi, Giuseppe</creator><creator>Astuto, Marinella</creator><creator>Oliveri, Francesco</creator><creator>Oliveri, Salvatore</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0372-8545</orcidid></search><sort><creationdate>20210101</creationdate><title>Fatal VAP-related pulmonary aspergillosis by Aspergillus niger in a positive COVID-19 patient</title><author>Trovato, Laura ; Calvo, Maddalena ; Migliorisi, Giuseppe ; Astuto, Marinella ; Oliveri, Francesco ; Oliveri, Salvatore</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c488t-f6f10e5b3806271d255e6c149dd9f4826c4581f8565831a19a36a2765cd308783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aspergillus niger</topic><topic>Case Report</topic><topic>Coinfection</topic><topic>Pulmonary aspergillosis</topic><topic>SARS-CoV-2</topic><topic>Ventilator-associated pneumonia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Trovato, Laura</creatorcontrib><creatorcontrib>Calvo, Maddalena</creatorcontrib><creatorcontrib>Migliorisi, Giuseppe</creatorcontrib><creatorcontrib>Astuto, Marinella</creatorcontrib><creatorcontrib>Oliveri, Francesco</creatorcontrib><creatorcontrib>Oliveri, Salvatore</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Respiratory medicine case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Trovato, Laura</au><au>Calvo, Maddalena</au><au>Migliorisi, Giuseppe</au><au>Astuto, Marinella</au><au>Oliveri, Francesco</au><au>Oliveri, Salvatore</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fatal VAP-related pulmonary aspergillosis by Aspergillus niger in a positive COVID-19 patient</atitle><jtitle>Respiratory medicine case reports</jtitle><addtitle>Respir Med Case Rep</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>32</volume><spage>101367</spage><pages>101367-</pages><artnum>101367</artnum><issn>2213-0071</issn><eissn>2213-0071</eissn><abstract>Invasive pulmonary aspergillosis, known as a complication in patients with severe respiratory syndromes, recently showed a correlation with COVID-19 pneumonia, and the clinical characteristics of COVID-19 associated pulmonary aspergillosis (CAPA) have been described. Unfortunately, infections by the Aspergillus genus are often diagnosed in post-mortem time, because of diagnostic delays and a rapid worsening of respiratory conditions. Literature data document, in fact, only few cases of COVID-19 Aspergillus niger coinfection. The aim of this study was to describe a case of a VAP-related probable pulmonary aspergillosis by Aspergillus niger in a COVID-19 patient. Despite the definition of fungal etiology and the rapid administration of antifungal therapy, the patient died while on ventilator support because of severe respiratory impairment.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33619451</pmid><doi>10.1016/j.rmcr.2021.101367</doi><orcidid>https://orcid.org/0000-0002-0372-8545</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2213-0071
ispartof Respiratory medicine case reports, 2021-01, Vol.32, p.101367, Article 101367
issn 2213-0071
2213-0071
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_99045e51ab2e4813a24a43fd55a1f0a0
source ScienceDirect; PubMed Central
subjects Aspergillus niger
Case Report
Coinfection
Pulmonary aspergillosis
SARS-CoV-2
Ventilator-associated pneumonia
title Fatal VAP-related pulmonary aspergillosis by Aspergillus niger in a positive COVID-19 patient
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T02%3A31%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fatal%20VAP-related%20pulmonary%20aspergillosis%20by%20Aspergillus%20niger%20in%20a%20positive%20COVID-19%20patient&rft.jtitle=Respiratory%20medicine%20case%20reports&rft.au=Trovato,%20Laura&rft.date=2021-01-01&rft.volume=32&rft.spage=101367&rft.pages=101367-&rft.artnum=101367&rft.issn=2213-0071&rft.eissn=2213-0071&rft_id=info:doi/10.1016/j.rmcr.2021.101367&rft_dat=%3Celsevier_doaj_%3ES2213007121000290%3C/elsevier_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c488t-f6f10e5b3806271d255e6c149dd9f4826c4581f8565831a19a36a2765cd308783%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/33619451&rfr_iscdi=true